SorenMGanttMD
Pediatric Infectious Disease • Seattle, WAAssistant Professor, Pediatrics, University of Washington School of Medicine
Dr. Gantt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4800 Sand Point Way NE
Seattle, WA 98105Phone+1 206-987-1909Fax+1 206-987-3890
Education & Training
University of WashingtonFellowship, Pediatric Infectious Diseases, 2003 - 2006- University of WashingtonResidency, Pediatrics, 2001 - 2003
New York University School of MedicineClass of 2001
Certifications & Licensure
WA State Medical License 2003 - 2015
Awards, Honors, & Recognition
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma Start of enrollment: 2017 Mar 13
- CT18 Infant Influenza Priming Study in Vaccine Naive Infants Start of enrollment: 2018 Nov 01
Publications & Presentations
PubMed
- 14 citationsCharacterization of adaptive-like γδ t cells in ugandan infants during primary cytomegalovirus infectionJessica Tuengel, Sanya Ranchal, Alexandra Maslova, Gurpreet Aulakh, Maria Papadopoulou
Viruses. 2021-10-03 - 71 citationsMyeloid derived suppressor cells are present at high frequency in neonates and suppress in vitro T cell responses.Ana L. Gervassi, Nicholas Lejarcegui, Sandra Dross, Amanda C. Jacobson, Grace Itaya
Plos One. 2014-09-23 - 61 citationsLevels of circumsporozoite protein in the Plasmodium oocyst determine sporozoite morphologyVandana Thathy, Hisashi Fujioka, Soren Gantt, Ruth S. Nussenzweig, Victor Nussenzweig
The EMBO Journal. 2002-04-01
Press Mentions
- Babies and Toddlers Are Getting COVID-19 Vaccines in Montreal as Part of a Clinical TrialNovember 25th, 2021
UBC Faculty of Medicine Researchers Receive Nearly $14M in Federal Funding for COVID-19 ResearchJune 25th, 2020
Cytomegalovirus Vaccine Candidate Found to Be Safe & Immunogenic in First-in-Humans TrialOctober 11th, 2018- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
